Literature DB >> 23774231

Isoflurane, a commonly used volatile anesthetic, enhances renal cancer growth and malignant potential via the hypoxia-inducible factor cellular signaling pathway in vitro.

Laura L Benzonana1, Nicholas J S Perry, Helena R Watts, Bob Yang, Iain A Perry, Charles Coombes, Masao Takata, Daqing Ma.   

Abstract

BACKGROUND: Growing evidence indicates that perioperative factors, including choice of anesthetic, affect cancer recurrence after surgery although little is known about the effect of anesthetics on cancer cells themselves. Certain anesthetics are known to affect hypoxia cell signaling mechanisms in healthy cells by up-regulating hypoxia-inducible factors (HIFs). HIFs are also heavily implicated in tumorigenesis and high levels correlate with poor prognosis.
METHODS: Renal cell carcinoma (RCC4) cells were exposed to isoflurane for 2 h at various concentrations (0.5-2%). HIF-1α, HIF-2α, phospho-Akt, and vascular endothelial growth factor A levels were measured by immunoblotting at various time points (0-24 h). Cell migration was measured across various components of extracellular matrix, and immunocytochemistry was used to analyze proliferation rate and cytoskeletal changes.
RESULTS: Isoflurane up-regulated levels of HIF-1α and HIF-2α and intensified expression of vascular endothelial growth factor A. Exposed cultures contained significantly more cells (1.81 ± 0.25 vs. 1.00 of control; P = 0.03) and actively proliferating cells (89.4 ± 2.80 vs. 64.74 ± 7.09% of control; P = 0.016) than controls. These effects were abrogated when cells were pretreated with the Akt inhibitor, LY294002. Exposed cells also exhibited greater migration on tissue culture-coated (F = 16.89; P = 0.0008), collagen-coated (F = 20.99; P = 0.0003), and fibronectin-coated wells (F = 8.21; P = 0.011) as along with dramatic cytoskeletal rearrangement, with changes to both filamentous actin and α-tubulin.
CONCLUSIONS: These results provide evidence that a frequently used anesthetic can exert a protumorigenic effect on a human cancer cell line. This may represent an important contributory factor to high recurrence rates observed after surgery.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23774231     DOI: 10.1097/ALN.0b013e31829e47fd

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  64 in total

1.  Biological processes and pathway changes in isoflurane-induced anesthesia revealed by bioinformatics analysis of gene expression profiles.

Authors:  Hai Wang; Yi Jin; Jinyan Dai
Journal:  J Anesth       Date:  2015-07-30       Impact factor: 2.078

2.  Cancer prognosis: can anesthesia play a role?

Authors:  Zhongcong Xie
Journal:  Anesthesiology       Date:  2013-09       Impact factor: 7.892

Review 3.  Relationship between Volatile Anesthetics and Tumor Progression: Unveiling the Mystery.

Authors:  Bo Jiao; Chun Yang; Nian-Nian Huang; Ning Yang; Jia Wei; Hui Xu
Journal:  Curr Med Sci       Date:  2018-12-07

Review 4.  Volatile anesthetics and AKI: risks, mechanisms, and a potential therapeutic window.

Authors:  Kyota Fukazawa; H Thomas Lee
Journal:  J Am Soc Nephrol       Date:  2014-02-07       Impact factor: 10.121

5.  Isoflurane Impacts Murine Melanoma Growth in a Sex-Specific, Immune-Dependent Manner: A Brief Report.

Authors:  Angela Meier; Emilie T E Gross; Jan M Schilling; Ruth Seelige; Yujin Jung; Endi Santosa; Stephen Searles; Tuo Lin; Xin M Tu; Hemal H Patel; Jack D Bui
Journal:  Anesth Analg       Date:  2018-06       Impact factor: 5.108

Review 6.  Perioperative events influence cancer recurrence risk after surgery.

Authors:  Jonathan G Hiller; Nicholas J Perry; George Poulogiannis; Bernhard Riedel; Erica K Sloan
Journal:  Nat Rev Clin Oncol       Date:  2017-12-28       Impact factor: 66.675

7.  Effect of sevoflurane on human hepatocellular carcinoma HepG2 cells under conditions of high glucose and insulin.

Authors:  Tadashi Nishiwada; Yoshitaka Kawaraguchi; Keiko Uemura; Hiroshi Sugimoto; Masahiko Kawaguchi
Journal:  J Anesth       Date:  2015-05-16       Impact factor: 2.078

8.  The effect of different anesthetics on tumor cytotoxicity by natural killer cells.

Authors:  Kazumasa Tazawa; Sophia Koutsogiannaki; Matthew Chamberlain; Koichi Yuki
Journal:  Toxicol Lett       Date:  2016-12-08       Impact factor: 4.372

Review 9.  Exploring the modulation of hypoxia-inducible factor (HIF)-1α by volatile anesthetics as a possible mechanism underlying volatile anesthetic-induced CNS injury.

Authors:  Emma K Giles; Andrew J Lawrence; Jhodie R Duncan
Journal:  Neurochem Res       Date:  2014-07-09       Impact factor: 3.996

Review 10.  Immune Modulation by Volatile Anesthetics.

Authors:  Lindsay M Stollings; Li-Jie Jia; Pei Tang; Huanyu Dou; Binfeng Lu; Yan Xu
Journal:  Anesthesiology       Date:  2016-08       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.